background: studies have shown controversial effects of obesity on major adverse cardiac events (mace) after percutaneous coronary intervention (pci). we sought to investigate the impact of the body mass index (bmi) on the mid-term outcome following successful pci. methods: between march 2006 and august 2008, 3948 patients underwent successful elective pci in tehran heart center, tehran, iran, ...

BACKGROUND Patients with diabetic nephropathy (DN) and coronary artery disease (CAD) represent a subset of patients with high cardiovascular morbidity and mortality. The optimal revascularization strategy using either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) remains controversial. The purpose of this study was to compare the clinical outcomes of PCI to ...

Primary percutaneous coronary intervention (PCI) is the recommended treatment for ST-elevation myocardial infarction (STEMI), according to American College of Cardiology and American Heart Association guidelines published in 1999 and 2004. In this study, hospital and patient predictors of same-day primary PCI use for STEMI were examined across the period from 2001 to 2005. Inpatient discharge d...

Primary percutaneous coronary intervention (PCI) is the preferred reperfusion method in patients with STelevation myocardial infarction (STEMI), when performed in a timely manner and by skilled operators. However, this strategy has shown to be limited in environments with lack of PCI facilities and delay in the first medical contact-toballoon time for logistic reasons. Pretreatment with fibrino...

PCI Express is a high-performance, general-purpose I/O Interconnect. It introduces AER (Advanced Error Reporting) concepts, which provide significantly higher reliability at a lower cost than the previous PCI and PCI-X standards. The AER driver of the Linux kernel provides a clean, generic, and architecture-independent solution. As long as a platform supports PCI Express, the AER driver shall g...

Controversy continues in the United States over the performance of percutaneous coronary intervention (PCI) at facilities without on-site cardiac surgery. After publication of the quantitative review by Keeley et al1 in 2003, the superiority of PCI over thrombolytic therapy for the treatment of ST-segment–elevation myocardial infarction (STEMI) was widely accepted. These findings further suppor...

OBJECTIVES This study sought to assess outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI) for unprotected left main (LM) disease. BACKGROUND Limited data are available on outcomes in patients with ST-segment elevation myocardial infarction undergoing LM PCI. METHODS Of 9,075 patients with ST-segment elevation myoc...

BACKGROUND The impact of primary percutaneous coronary intervention (PCI) for acute ST-elevated myocardial infarction (STEMI) on the incidence of ischemic mitral regurgitation (IMR) is unclear. METHODS AND RESULTS Between January 2000 and December 2004, 318 patients presenting with first acute STEMI were enrolled in this study. Two hundred and twelve (66.67%) patients received PCI (PCI group)...

We analyzed the safety and the efficacy of the treatment with elective percutaneous coronary intervention (PCI) in patients with coronary heart disease complicated with cardiac insufficiency. We enrolled 217 patients diagnosed with chronic ischemic heart disease complicated with cardiac failure. According to the type of treatment they received, patients were divided into 3 groups: i) The conser...